Insider Trading Alert - OVTI, CSOD And OHI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, March 28, 2014, 73 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $105.75 to $179,310,826.89.

Highlighted Stocks Traded by Insiders:

OmniVision Technologies (OVTI) - FREE Research Report

Yang Hongli who is Chief Operating Officer at OmniVision Technologies sold 18,802 shares at $17.50 on March 28, 2014. Following this transaction, the Chief Operating Officer owned 39,268 shares meaning that the stake was reduced by 32.38% with the 18,802-share transaction.

The shares most recently traded at $17.34, down $0.16, or 0.92% since the insider transaction. Historical insider transactions for OmniVision Technologies go as follows:

  • 4-Week # shares sold: 7,000
  • 12-Week # shares sold: 7,000
  • 24-Week # shares sold: 9,000

The average volume for OmniVision Technologies has been 1.3 million shares per day over the past 30 days. OmniVision Technologies has a market cap of $965.4 million and is part of the technology sector and electronics industry. Shares are down 0.58% year-to-date as of the close of trading on Friday.

OmniVision Technologies, Inc. engages in designing, developing, and marketing semiconductor image-sensor devices worldwide. The company has a P/E ratio of 11.0. Currently there are 3 analysts that rate OmniVision Technologies a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OVTI - FREE

TheStreet Quant Ratings rates OmniVision Technologies as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full OmniVision Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cornerstone OnDemand (CSOD) - FREE Research Report

Miller Adam L who is President & CEO at Cornerstone OnDemand sold 16,500 shares at $46.56 on March 28, 2014. Following this transaction, the President & CEO owned 3.6 million shares meaning that the stake was reduced by 0.46% with the 16,500-share transaction.

The shares most recently traded at $47.05, up $0.49, or 1.03% since the insider transaction. Historical insider transactions for Cornerstone OnDemand go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 99,200
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 187,800
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 309,600

The average volume for Cornerstone OnDemand has been 584,800 shares per day over the past 30 days. Cornerstone OnDemand has a market cap of $2.4 billion and is part of the technology sector and computer software & services industry. Shares are down 13.23% year-to-date as of the close of trading on Friday.

Cornerstone OnDemand, Inc. provides cloud-based talent management solutions delivered as software-as-a-service. It offers four integrated clouds for recruiting, learning management, performance management, and extended enterprise. Currently there are 6 analysts that rate Cornerstone OnDemand a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSOD - FREE

TheStreet Quant Ratings rates Cornerstone OnDemand as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally high debt management risk and feeble growth in its earnings per share. Get the full Cornerstone OnDemand Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Omega Healthcare Investors (OHI) - FREE Research Report

Booth Daniel J who is Chief Operating Officer at Omega Healthcare Investors sold 20,000 shares at $33.50 on March 28, 2014. Following this transaction, the Chief Operating Officer owned 172,197 shares meaning that the stake was reduced by 10.41% with the 20,000-share transaction.

The shares most recently traded at $33.31, down $0.19, or 0.58% since the insider transaction. Historical insider transactions for Omega Healthcare Investors go as follows:

  • 4-Week # shares bought: 32,424
  • 12-Week # shares bought: 32,424
  • 24-Week # shares bought: 78,494
  • 24-Week # shares sold: 9,975

The average volume for Omega Healthcare Investors has been 1.3 million shares per day over the past 30 days. Omega Healthcare Investors has a market cap of $4.2 billion and is part of the financial sector and real estate industry. Shares are up 11.88% year-to-date as of the close of trading on Friday.

Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. The stock currently has a dividend yield of 5.95%. The company has a P/E ratio of 22.6. Currently there is 1 analyst that rates Omega Healthcare Investors a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OHI - FREE

TheStreet Quant Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Omega Healthcare Investors Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists